Annual report pursuant to Section 13 and 15(d)

OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)

v3.20.4
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
12 Months Ended
Dec. 31, 2020
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table presents information related to stock options at December 31, 2020:

 

 

Options Outstanding

   

Options Exercisable

 
                 

Weighted

         
                 

Average

   

Exercisable

 
 

Exercise

   

Number of

   

Remaining Life

   

Number of

 
 

Price

   

Options

   

In Years

   

Options

 
 

$

2.51-5.00

     

1,767,132

     

7.6

     

1,512,552

 
   

5.01-7.50

     

1,413,032

     

6.5

     

965,817

 
   

7.51-10.00

     

323,333

     

5.5

     

205,412

 
   

10.01-12.50

     

65,000

     

9.4

     

44,166

 
           

3,568,497

     

7.0

     

2,727,947

 

 

 

Options Outstanding

   

Options Exercisable

 
                 

Weighted

         
                 

Average

   

Exercisable

 
 

Exercise

   

Number of

   

Remaining Life

   

Number of

 
 

Price

   

Options

   

In Years

   

Options

 
 

$

5.00

     

1,527,666

     

3.96

     

1,452,665

 

 

Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the Plan for the two years ended December 31, 2020 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at January 1, 2019

    3,135,828     $ 5.34       5.2       -  

Grants

    1,599,053     $ 5.99       10.0       -  

Exercised

    (550,077

)

  $ 5.44                  

Forfeited/expired

    (204,000

)

  $ 5.51                  

Outstanding at December 31, 2019

    3,980,804     $ 5.58       6.3     $ 3,130,791  

Grants

    1,120,000       4.98       10.0     $ -  

Exercised

    (1,203,223

)

  $ 5.08                  

Forfeited/expired

    (329,084

)

  $ 5.19                  

Outstanding at December 31, 2020

    3,568,497     $ 5.59       7.00     $ 110,961  

Exercisable at December 31, 2020

    2,727,947     $ 5.54       6.43     $ 66,899  

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following assumptions were used in determining the fair value of employee options for the year ended December 31, 2019:

 

Risk-free interest rate

    1.45% to 2.74

%

Dividend yield

    0

%

Stock price volatility

    86.74% to 91.55

%

Expected life

 

5 to 10 years

 

Weighted average grant date fair value

  $ 5.75  

 

Risk-free interest rate

    2.33% - 2.40

%

Dividend yield

    0

%

Stock price volatility

    89.97

%

Expected life

 

0.12– 2 years

 

 

   

2020

   

2019

 

Risk-free interest rate

    0.42% - 1.83

%

    1.45% to 2.74

%

Dividend yield

    0

%

    0

%

Stock price volatility

    86.51% to 93.43

%

    86.74% to 91.55

%

Expected life

 

5 – 10 years

   

5-10 years

 

Weighted average grant date fair value

  $ 4.03     $ 5.75  

 

Risk-free interest rate

    1.56

%

Dividend yield

    0

%

Stock price volatility

    71.0

%

Expected life

 

5 years

 

 

Risk-free interest rate

    0.36% to 0.52

%

Dividend yield

    0

%

Stock price volatility

    125.16% to 126.03

%

Expected life

 

5 – 6 years

 

Weighted average grant date fair value

  $ 4.51  

 

Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block] The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at December 31, 2020:
 

Exercise

   

Number

 

Expiration

 

Price

   

Outstanding

 

Date

 

$

3.75

     

10,000

 

January 2021

 

$

4.38

     

548,938

 

April 2021

 

$

4.80

     

125,000

 

February 2025

 

$

6.16

     

568,910

 

November 2027

 

$

6.85

     

193,352

 

July 2021 to August 2021

           

1,446,200

   

 

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of the warrant activity for the two years ended December 31, 2020 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at January 1, 2019

    4,579,511     $ 4.73       1.5     $ 1,924,388  

Issued

    568,910     $ 6.16       7.0       -  

Exercised

    (2,170,406

)

  $ 3.99                  

Expired

    (233,297

)

  $ 7.24                  

Outstanding at December 31, 2019

    2,744,718     $ 5.40       2.2     $ 3,410,763  

Issued

    125,000       4.80       4.2          

Exercised

    (580,487

)

  $ 3.89                  

Expired

    (843,031

)

  $ 6.29       -       -  

Outstanding at December 31, 2020

    1,446,200     $ 5.44       3.3     $ 1,500  
                                 

Vested and expected to vest at December 31, 2020

    1,446,200     $ 5.27       3.2     $ 1,500  

Exercisable at December 31, 2020

    1,446,200     $ 5.27       3.2     $ 1,500  

 

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes the restricted stock activity for the Two years ended December 31, 2020:

 

Restricted shares issued as of January 1, 2019

    -  

Granted

    376,000  

Vested and issued

    (113,332

)

Restricted shares issued as of December 31, 2019

    262,668  

Granted

    175,000  

Vested and issued

    (219,334

)

Vested restricted shares as of December 31, 2020

    -  

Unvested restricted shares as of December 31, 2020

    218,334  

 

Restricted shares issued as of January 1, 2019

    -  

Granted

    40,000  

Restricted shares issued as of December 31, 2019

    40,000  

Granted

    1,380,716  

Vested

    -  

Vested restricted shares as of December 31, 2020

    732,465  

Unvested restricted shares as of December 31, 2020

    648,251  

 

Schedule of Warrants or Rights, Shares Authorized, Exercise Price Range [Table Text Block]

The following table presents information related to warrants (ViralClear) at December 31, 2020:

 

 

Exercise

   

Number

 

Expiration

 

Price

   

Outstanding

 

Date

 

$

5.00

     

473,772

 

November 2027

   

10.00

     

6,575

 

May 2025

           

480,347

   

 

Viral Clear [Member]  
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the ViralClear Plan for the two years ended December 31, 2020 is as follows:

 

                   

Weighted-Average

 
           

Weighted-Average

   

Remaining

 
   

Shares

   

Exercise Price

   

Contractual Term

 

Outstanding at January 1, 2019

    -                  

Grants

    575,000     $ 5.00       -  

Exercised

    -                  

Forfeited/expired

    -                  

Outstanding at December 31, 2019

    575,000     $ 5.00       9.29  

Grants

    1,599,173     $ 5.31       9.59  

Exercised

    -                  

Forfeited/expired

    (646,507

)

  $ 5.77          

Outstanding at December 31, 2020

    1,527,666     $ 5.00       3.96  

Exercisable at December 31, 2020

    1,452,665     $ 5.00       3.68